AGIO
Agios Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.10
−0.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.93x
- Price / sales
- 20.10x
- Price / cash flow
- -5.48x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 14.13x
- EV / EBITDA
- -3.33x
- EV / EBIT
- -3.03x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026